Research progress on radical concurrent chemoradiotherapy for locally advanced esophageal cancer / 中华放射肿瘤学杂志

ABSTRACT

The current standard treatment modality for unresectable locally advanced esophageal cancer is radical concurrent chemoradiotherapy. In this article, research progress on radiotherapy techniques, differences in radiotherapy dose and target volume, exploration in concurrent chemotherapy and immunotherapy was reviewed, aiming to provide reference and evidence for clinical treatment.